Literature DB >> 21705976

Pathophysiology of beta thalassaemia.

Raffaella Origa1, Renzo Galanello.   

Abstract

In beta thalassemia, unbalanced alpha globin chain synthesis results in severely rheologically compromised erythrocytes with premature destruction in the peripheral circulation and ineffective erythropoiesis within the bone marrow and in extramedullary sites. In nontransfused beta thalassemia patients, erythropoiesis,anemia and hypoxia down-regulate hepcidin, the master regulator of iron homeostasis. Hepcidin deficiency in turn allows excessive duodenal iron absorption and development of systemic iron overload. In regularly transfused patients iron overload is mostly due to red cell breakdown. When the iron binding capacity of transferrin is saturated, iron can appear in the serum in a free form, called Non-Transferrin-Bound Iron, a powerful catalyst for the formation of free radicals, capable of causing oxidative stress and damage to mitochondria, lysosomes, lipid membranes, proteins, and DNA. Apart from the iron overload-related complications, other pathological conditions such as bone disease, gallstones and thromboembolic events occur in a relevant proportion of subjects with thalassemia.

Entities:  

Mesh:

Year:  2011        PMID: 21705976

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  9 in total

Review 1.  β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies.

Authors:  Stefano Rivella
Journal:  Haematologica       Date:  2015-04       Impact factor: 9.941

2.  Dynamic changes in murine erythropoiesis from birth to adulthood: implications for the study of murine models of anemia.

Authors:  Lixiang Chen; Jie Wang; Jing Liu; Hua Wang; Christopher D Hillyer; Lionel Blanc; Xiuli An; Narla Mohandas
Journal:  Blood Adv       Date:  2021-01-12

3.  Assessment of the red cell proteome of young patients with unexplained hemolytic anemia by two-dimensional differential in-gel electrophoresis (DIGE).

Authors:  Katharina von Löhneysen; Thomas M Scott; Katrin Soldau; Xiuling Xu; Jeffrey S Friedman
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

Review 4.  From the Cradle to the Grave: The Role of Macrophages in Erythropoiesis and Erythrophagocytosis.

Authors:  Thomas R L Klei; Sanne M Meinderts; Timo K van den Berg; Robin van Bruggen
Journal:  Front Immunol       Date:  2017-02-02       Impact factor: 7.561

5.  Epidural anesthesia for laparoscopic cholecystectomy in a patient with sickle cell anemia, beta thalassemia, and Crohn's disease -A case report-.

Authors:  Sema Şanal Baş; Onur Ozlü
Journal:  Korean J Anesthesiol       Date:  2012-10-12

6.  Protection against oxidative stress in beta thalassemia/hemoglobin E erythrocytes by inhibitors of glutathione efflux transporters.

Authors:  Chatchai Muanprasat; Chokdee Wongborisuth; Nutthapoom Pathomthongtaweechai; Saravut Satitsri; Suradej Hongeng
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

7.  Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Nicos Skordis; Christos Kattamis; Michael Angastiniotis; Mehran Karimi; Mohd Abdel Daem Mohd Yassin; Ahmed El Awwa; Iva Stoeva; Giuseppe Raiola; Maria Concetta Galati; Elsaid M Bedair; Bernadette Fiscina; Mohamed El Kholy
Journal:  Indian J Endocrinol Metab       Date:  2013-01

8.  Serum hepcidin and chronic obstructive pulmonary disease.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Ann Thorac Med       Date:  2012-07       Impact factor: 2.219

9.  Amino acids and fatty acids in patients with beta thalassemia major.

Authors:  Tugba Koca; Duran Canatan; Ahmet Rifat Örmeci; Yavuz Savas Koca; Handan Duman; Aslı Baykal; Mustafa Akcam
Journal:  Acta Biomed       Date:  2020-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.